Thursday, February 27, 2020

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

Structure of a novel enzyme linked to cell growth and cancer cracked

Structure of a novel enzyme linked to cell growth and cancer cracked

A new UC Riverside-led study could lead to the development of drugs that target liver and other cancers. RNA, or ribonucleic acid, is present in...
Snail venom to pain relief: how conotoxins can be used in pain therapy

Snail venom to pain relief: how conotoxins can be used in pain therapy

Conotoxins, found in the venom of the one of the sea’s deadliest creatures, the cone snail, have the potential to become a new class...
Could lenalidomide delay the onset of myeloma-related bone, organ damage?

Could lenalidomide delay the onset of myeloma-related bone, organ damage?

According to the Eastern Cooperative Oncology Group, lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage. Published in the...
Oral cholera vaccine: IVI awarded $4.5 million grant to increase accessibility

Oral cholera vaccine: IVI awarded $4.5 million grant to increase accessibility

The International Vaccine Institute (IVI) has received a $4.5 million grant from the Bill & Melinda Gates Foundation to increase accessibility of oral cholera...
C difficile infection: The search for new Clostridioides difficile vaccine

C difficile infection: The search for new Clostridioides difficile vaccine

University of Exeter researchers have made a breakthrough in the quest for a new vaccine for killer hospital bug Clostridioides difficile (C difficile infection). The...
Clarithromycin resistance has doubled in two decades

Clarithromycin resistance has doubled in two decades

Clarithromycin resistance – a commonly-used antibiotic for treating harmful bacteria related to a variety of stomach conditions – has more than doubled in 20...
Tetra Bio-Pharma: global developer of cannabinoid-derived products

Tetra Bio-Pharma: global developer of cannabinoid-derived products

Dr Guy Chamberland explains how Tetra Bio-Pharma is taking a pharmaceutical pathway to discovering and developing cannabinoid-derived products. In an industry that could aptly be...
Survey shows menopausal women being prescribed 'inappropriate' antidepressants

Survey shows menopausal women being prescribed ‘inappropriate’ antidepressants

Nearly 40% of menopausal women are being prescribed antidepressants to help manage their symptoms, despite four out of five describing the treatment as ‘inappropriate.’ According...
Scientists discover new antibiotic in tropical Mexican forest

Scientists discover new antibiotic in tropical Mexican forest

An antibiotic produced by a soil bacterium has been discovered in a Mexican tropical forest that may help lead to a "plant probiotic," more...
Novel compound can interrupt malaria parasite's lifecycle

Novel compound can interrupt malaria parasite’s lifecycle

Scientists have proven that a novel compound inhibits key enzymes to interrupt the malaria parasite's lifecycle in human organisms and prevents transmission to vector...
Treatment of pain and inflammation with Tetra Bio-Pharma’s CAUMZ kit

Treatment of pain and inflammation with Tetra Bio-Pharma’s CAUMZ kit

CAUMZ is a non-opioid alternative in Phase 3 development for the treatment of pain and inflammation, and Tetra are one step closer to bringing...

China’s organ transplant crimes delivered to UN Human Rights Council

Today, China’s forced organ harvesting crimes were announced at the United Nations Human Rights Council (UNHRC) for the first time in the Council’s history. Organ...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest